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Abstract:  The  bioactivity  of  polyphenols  is  closely  linked  to  their  ability  to  interact  
with  biological  membranes.  The  study  evaluates  the  in  vitro  effect  of  quercetin  and 
epigallocatechin on the membrane anisotropy and transmembrane potential of peripheral 
blood  mononuclear  cells  (PBMCs)  isolated  from  26  type  2  diabetes  mellitus  patients 
compared to 25 age matched controls. The in vitro assays were analyzed in correlation with 
the  biochemical  and  inflammatory  profile  of  the  subjects  and  with  insulin  resistance 
parameters (HOMA-IR, plasma resistin) as well. For type 2 diabetes patients, the increase 
of HOMA-IR and resistin concentration was associated with a significant decrease of the 
PBMCs  membrane  anisotropy.  The  two  tested  polyphenols  induced  a  dose-dependent 
hyperpolarizing  effect  and  stiffening  of  the  cell  membranes  for  all  tested  subjects. 
Physiological  levels  of  quercetin  and  epigallocatechin  gallate  had  the  tendency  to 
normalize the PBMCs membrane anisotropy of the cells isolated from diabetes patients, 
bringing it to the level of cells isolated from normoglycemic ones. Epigallocatechin gallate 
induced higher effects compared to quercetin on the membranes isolated from subjects 
with higher cardiovascular risk. The decrease of membrane fluidity and the hyperpolarizing 
effect could explain the cardiovascular protective action of the tested compounds. 
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1. Introduction 
Vegetable based diets are considered health-promoting; their beneficial effects are largely attributed 
to  the  rich  polyphenol  composition  [1,2].  Numerous  data  support  the  antioxidant  potential  of  the 
phenolic phytochemicals and many other disease-preventative characteristics  such as  antimicrobial 
properties,  anti-cancer  activity,  cardiovascular-related  effects  (reduction  of  dyslipidemia  and 
atherosclerosis, endothelial dysfunction and hypertension, platelet activation and thrombosis) and the 
capacity to modulate blood glucose [3,4]. Even if a large number of studies have identified cellular 
targets that could be involved in the health promoting actions of dietary plant polyphenols, there are 
still controversies regarding the actual molecular interactions of polyphenols with those targets [2]. 
The bioactivity of flavonoids is closely linked to their ability to interact with membranes, since 
many of these compounds generate a cell response even if they are not internalized [5,6]. Polyphenols 
could affect cell function by modifying plasma membrane structure and physical characteristics such 
as fluidity and electrical properties [2,7–11]. Epigallocatechin gallate (EGCG), for example, interacts 
with  the  lipid  rafts,  thus  disturbing  the  downstream  activation  of  signals  involved  in  the  allergic 
response and in cell proliferation of colon cancer cells [2,12]. 
Since  polyphenol  interaction  with  membrane  structures  represents  a  major  issue  in  modulating 
cellular  events,  the  present  study  evaluates  the  in  vitro  short  term  effect  of  quercetin  (Q)  and 
epigallocatechin gallate (EGCG) on the membrane fluidity and transmembrane potential of peripheral 
blood  mononuclear  cells  (PBMCs)  isolated  from  patients  with  type  2  diabetes  mellitus  (T2D) 
compared to normoglycemic subjects. These effects of Q and EGCG on membrane properties were 
correlated  with  the  biochemical  and  inflammatory  profile  of  the  patients  as  well  as  the  insulin 
resistance parameters, aiming to evaluate if these biophysical mechanisms could explain the beneficial 
roles of polyphenols in cardiovascular disease (CVD) associated with hyperglycemia. The results of 
this study show which categories of patients might particularly benefit from the effects of the tested 
compounds on their cardiovascular risk. These studies could also be connected to the present trend of 
the general population of consuming large amounts of polyphenolic supplements. 
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2. Results and Discussion 
Since we were aiming at finding the types of patients that could benefit from the effects of the 
polyphenols, the analysis of the in vitro results was performed in relation with the fasting plasma glucose 
level (Gli) and also with the total cholesterol (TC) level. For this purpose, we divided the subjects either 
in two groups (depending only on Gli) or in four sub-groups (depending both on Gli and the TC level).  
Preliminary experiments proved that the two fluorescent probes (TMA-DPH and DiBAC4(3)) do not 
interfere with each other, nor with the tested compounds (Q and EGCG), and that they can be used in 
double staining experiments. We also assayed the response of cells (PBMCs) isolated from healthy donor 
to different levels of exposure (10 µ M, 50 µ M and 100 µ M) of each of the tested compounds. These 
results, correlated with literature data showing that the physiological levels of plasma Q and EGCG 
reached  after  polyphenol  rich  meals  are  about  2–10  µ M  [13,14];  this  made  us  select  the  10  µ M 
concentration to be tested for the cell isolated from the selected subjects.  
2.1. Biochemical and Inflammatory Profile of the Selected Patients 
The glycated haemoglobin (HbA1c) was 8.15 ±  1.65% for the diabetes group (HG) and 5.35 ±  0.46% 
for the age-matched normoglicemia (NG) group (p < 0.01). Statistical analysis showed that there are 
significant differences between the diabetes patients and the normoglycemia subjects regarding the Gli, 
triglycerides (TG, p = 0.0108) and urea levels (p = 0.033). The significant differences are marked with 
an asterisc (*) in Figure 1. The uric acid levels (5.02 ±  1.52 mg/dL for NG group vs. 5.25 ±  1.44 mg/dL for 
HG  group),  as  well  as  hepatic  tests  (AST—23.26  ±   9.95  IU  (International  Units)  for  NG  vs.  
22.00 ±  8.91 IU for HG and ALT—24.27 ±  20.03 IU for NG vs. 31.29 ±  20.32 IU for HG) had 
comparable values for the two groups. 
Figure 1. Biochemical characterization for HG and NG groups. Statistically significant 
different parameters are marked with an asterisc (*). 
 
The biochemical parameters for the subgroups, defined according both to their TC and Gli levels, 
are presented in Table 1. No significant differences were recorded between the 4 subgroups of patients 
for the triglycerides (TG) and high density lipoproteins (HDL) levels; the low density lipoproteins Int. J. Mol. Sci. 2012, 13  4842 
 
 
(LDL) level was significantly higher in the hypercholesterolemic (HC) subgroups compared to the  
age-matched normocholesterolemic (NC) subgroups.  
Table 1. Biochemical characterization of the subjects, divided into subgroups depending 
on their fasting plasma glucose and cholesterol levels. 
Biochemical parameters  NGNC (n = 15)  NGHC (n = 10)  HGNC (n = 12)  HGHC (n = 14) 
Gli (mg/dL)  94.95 ±  8.25  90.74 ±  9.11  172.33 ±  82.07 *
,a  205.48 ±  115.21 *
,a 
HbA1c (%)  5.26 ±  0.45  5.80 ±  0.54  7.80 ±  1.67 *
,a  9.55 ±  0.21 *
,a 
TC (mg/dL)  167.29 ±  21.78  226.67 ±  16.72 *
,b  164.25 ±  22.92  232.91 ±  39.92 *
,b 
TG (mg/dL)  92.50 ±  39.92  123.11 ±  74.39  134.17 ±  38.32  146.10 ±  45.56 
HDL (mg/dL)  43.86 ±  9.69  49.83 ±  6.68  35.63 ±  8.21  52.39 ±  13.51 
LDL (mg/dL)  104.14 ±  17.73  148.67 ±  11.68 *
,b  91.60 ±  34.51  142.70 ±  24.21 *
,b 
AST (U/L)  24.43 ±  12.15  21.50 ±  4.11  20.90 ±  9.49  23.57 ±  8.67 
ALT (U/L)  26.71 ±  23.24  20.00 ±  10.72  28.90 ±  14.55  34.71 ±  27.56 
Urea (mg/dL)  29.62 ±  7.52  31.46 ±  12.82  51.20 ±  29.67  32.80 ±  19.31 
Creatinine (mg/dL)  0.97 ±  0.21  0.80 ±  0.21  1.33 ±  0.94  0.93 ±  0.24 
Uric acid (mg/dL)  5.57 ±  1.51  4.06 ±  1.01  5.44 ±  1.59  4.97 ±  1.25 
* p < 0.05; 
a vs. NGNC subgroup; 
b vs. NC matched group (NGHC vs. NGNC and HGHC vs. HGNC). 
Subgroups:  NGNC,  normogycemia-normocholesterolemia;  NGHC,  normoglycemia-hyper-cholesterloemia; 
HGNC, hyperglycemia-normocholesterolemia; HGHC, hypergycemia-hyper-cholesterolemia.  
The monocytechemoatractant protein-1 (MCP-1) level was significantly higher for diabetes patients 
compared to the normoglycemia group, but the intercellular adhesion molecule-1 (ICAM-1) levels 
were  not  different  (Table  2).  For  C-reactive  protein  (CRP)  level,  the  coefficient  of  variation  was 
extremely high (90% for the normglycemia group and 129% for the diabetes group). As expected, the 
resistin and homeostatic model analysis for insulin resistance (HOMA-IR) are significantly different in 
the control and diabetes groups. The standard error values in cases of the HG group are extremely high, 
as the selected patients, even being all diagnosticated with T2D, were in different stages of the disease 
and were treated with different oral anti-hyperglycemic agents.  
Table 2. The inflammatory markers and insulin resistance parameters for NG and HG groups. 
Parameter  NG (n = 25)  HG (n = 26) 
CRP (mg/L)  1.64 ±  1.47  2.19 ±  2.84 
ICAM-1 (ng/mL)  3.53 ±  1.14  3.77 ±  2.07 
MCP-1 (pg/mL)  156.63 ±  73.66  218.83 ±  107.58 * 
Insulin (µIU/mL)  11.99 ±  1.87  15.12 ±  10.82 
Resistin (ng/mL)  103.39 ±  45.15  132.80 ±  29.42 * 
HOMA-IR  2.80 ±  0.64  6.90 ±  4.71 * 
* p < 0.05. 
The inflammatory markers for the subgroups of patients are presented in Table 3. 
The statistical analysis revaled higher levels of CRP in the HC subgroups compared to the NC ones; 
however,  the  differences  were  not  statistically  significant  due  to  the  high  value  of  the  standard 
deviations  compared  to  the  average  for  each  group  and  subgroup.  The  ICAM-1  levels  were  not Int. J. Mol. Sci. 2012, 13  4843 
 
 
different  between  the  study  subgroups.  The  MCP-1  levels  were  significantly  increased  in 
hypercholesterolemia subgroups, compared to normocholesterolemia ones, for patients with normal 
levels as well as pathological levels of fasting plasma glucose. 
Table  3.  The  inflammatory  marker  values  of  the  subjects  divided  into  subgroups, 
depending on their fasting plasma glucose and cholesterol levels. 
Inflammatory markers  NGNC (n = 15)  NGHC (n = 10)  HGNC (n = 12)  HGHC (n = 14) 
CRP (mg/L)  1.55 ±  1.36  1.84 ±  1.78  1.42 ±  1.38  2.86 ±  3.59 
ICAM-1 (ng/mL)  3.44 ±  1.08  3.66 ±  1.29  3.91 ±  1.84  3.66 ±  2.31 
MCP-1 (pg/mL)  121.11 ±  47.78  206.36 ±  76.54 *  177.27 ±  85.75  254.45 ±  114.35 * 
* p < 0.05, (each HC subgroup was compared to the matching NC subgroup). 
Insulin was not statistically different between the four study subgroups. The resistin level and the 
HOMA-IR were significantly higher for HGNC and HGHC patients compared to the NGNC subgroup 
(Table 4). 
Table 4. Insulin resistance parameters for the subjects divided into subgroups, depending 
on their fasting plasma glucose and cholesterol levels. 
Parameter  NGNC (n = 15)  NGHC (n = 10)  HGNC (n = 12)  HGHC (n = 14) 
Resistin (ng/mL)  95.29 ±  47.46  111.50 ±  43.96  128.86 ±  28.49 *  136.03 ±  31.15 * 
HOMA-IR  2.96 ±  0.73  2.54 ±  0.38  6.53 ±  4.81 *  7.27 ±  4.81 * 
Insulin (µ IU/mL)  12.50 ±  2.20  11.24 ±  0.88  14.38 ±  3.79  15.73 ±  14.54 
* p < 0.05, compared to NGNC group; IU: International Units. 
2.2. Evaluation of Q and EGCG Effect on PBMCs Membrane Parameters  
2.2.1. Preliminary Experiments 
Preliminary experiments proved that the maximum emission wavelength for the polyphenols is 
different from that of the fluorescent probes, so they do not interfere with each other. The data also 
demonstrated (personal results, in press) that the two probes do not interfere with each other and that 
they can be used in double staining experiments (Figure 2). As Q is dissolved in DMSO, we also 
checked the influence of the solvent on the cell membrane parameters (for PBMCs isolated from 
healthy  subjects).  The  solvent  induced  only  an  effect  of  0.28–0.30%,  which  can  be  considered 
negligible;  therefore  the  changes  in  the  cell  membrane  anisotropy  were  entirely  attributable  
to quercetin. 
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Figure  2.  Fluorescence  emission  spectra  of  blood  mononuclear  cells  (PBMCs)  from  a 
healthy  donor,  labeled  with  DiBAC4(3),  TMA-DPH  and  DiBAC4(3)  +  TMA-DPH 
respectively (excitation at 493 nm). 
 
2.2.2. Evaluation of Q and EGCG Concentration Effect on PBMC Membrane Parameters 
Data  from  the  literature  state  that  the  physiological  levels  of  plasma  quercetin  reached  after 
polyphenol rich meals is about 2–10 µM, with 20–100 µM being considered a supraphysiological 
concentration [14]. We wanted to see if there were differences between the in vitro short term effects 
of  both  physiological  and  supraphysiological  concentrations  of  the  tested  compounds  on  the 
biophysical parameters of the PBMCs membrane. For this purpose, we used cells isolated from two 
healthy donors, which were incubated for 20 min at room temperature with 10 µ M, 50 µ M and 100 µ M of 
each of the tested compounds. The fluorescence intensity of DiBAC4(3) and TMA-DPH labeled cells 
were registered at baseline and after incubation with the tested polyphenols, in triplicate. 
In order to establish the time the polyphenols need to induce an effect on the cell membrane, we 
assayed the anisotropy and the transmembrane potential after 5 min, 10 min, 20 min and 30 min of 
incubation  with  the  tested  compounds.  We  observed  that,  at  20  min,  the  maximum  effect  was 
registered;  the  anisotropy  and  transmembrane  potential  did  not  change  at  longer  incubation  times 
(insert in Figure 3).  
Both tested compounds lead to an increase of the membrane anisotropy, evaluated by means of 
TMA-DPH anisotropy; the increase of the stimuli concentration resulting in a higher anisotropy value 
(Figure 3), suggesting that increasing concentration of both polyphenols makes the cell membrane 
more rigid, as anisotropy and fluidity are inversely correlated [15]. 
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Figure 3. Q and EGCG induce a dose-dependent relative anisotropy increase (membrane 
stiffening) of PBMCs isolated from healthy donors. Insert presents preliminary data to set 
the incubation time. 
 
Q  and  EGCG  also  induced  a  dose-dependent  membrane  hyperpolarization,  expressed  by  the 
decrease of the DiBAC4(3) fluorescence intensity in treated cells compared to those untreated (Figure 4). 
Figure  4.  Dose-dependent  relative  hyperpolarizing  effect  of  Q  and  EGCG  on  PBMCs 
isolated from healthy donors. Insert presents preliminary data to set the incubation time. 
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2.2.3. Effect of 10 µM of Q and EGCG on PBMCs Membrane Properties 
The effect of 10 µ M for each of the two stimuli was further evaluated on PBMCs isolated from all the 
selected patients, following 20 min incubation of the cells with the tested compounds. The effects of the 
tested compounds were first analyzed depending on the fasting plasma glucose of the patients. 
Baseline (unstimulated) PBMCs membrane anisotropy for the diabetes patients was significantly 
lower compared to the r value corresponding to the normoglycemia subjects, regardless of their TC 
level (0.0632 ±  0.0187 compared to 0.0766 ±  0.0147, p = 0.005). In vitro incubation of the cells with 
polyphenols led to an increase of the membrane anisotropy (stiffening of the cell membrane) in all 
cases. The effects were higher in the case of hyperglycemia patients for both compounds; also, EGCG 
induces a stronger increase of the membrane anisotropy in both groups, compared to Q. Physiological 
levels of Q and EGCG tend to normalize the PBMCs membrane anisotropy values of the cells isolated 
from hyperglycemia patients, making it similar to that of PBMCs isolated from controls (Figure 5). 
Figure  5.  Q  and  EGCG  effect  on  membrane  anisotropy  for  NG  and  HG  patients  
(a) absolute anisotropy  values; (b) % increase  of the membrane anisotropy (calculated 
according to Equation (2)) for the two groups under the effect of Q and EGCG (* denotes 
statistically significant differences between the baseline anisotropy values for HG group 
compared to NG group). 
 
(a) 
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The fluidity of a membrane is basically determined by the lipid composition of the cell membrane 
(phospholipid kind, phospholipids fatty acids composition and cholesterol content within the membrane) 
and  the  external  temperature.  Also,  the  membrane  properties  are  directly  influenced  by  their 
microenvironment [16–22]. As there is also evidence that membrane composition of immune cells is 
influenced  by  dietary  intake  of  fatty  acids  [23],  our  experiments  were  performed  on  the  same  cell 
population exposed to the short-time action of polyphenols in comparison with untreated cells. Results 
were analyzed as a function of both Gli and TC values of the subjects, for the four subgroups of patients. 
The  baseline  values  for  the  membrane  anisotropy  were  higher  for  the  cells  isolated  from  
normoglycemia-normocholesterolemia (NGNC) subjects, compared to the other three subgroups; values 
were  significantly  higher  for  NGNC  subgroup  compared  to  both  HGNC  (0.078603  ±   0.0126  vs. 
0.063017 ±  0.0232, p = 0.033) and HGHC subgroups (0.078603 ±  0.0126 vs. 0.063389 ±  0.0148,  
p = 0.005). Patients affected by hypercholesterolemia, associated or not to hyperglycemia showed a 
reduced anisotropy value. The effect of the two tested compounds was the lowest on the more rigid 
membranes  from  the  NGNC  subgroup  (0.2%  effect  for  Q  and  4.58%  for  EGCG).  Q  induced  the 
highest effect on cells isolated from NGHC patients; EGCG had stronger effects on cells isolated from 
hypercholesterolemia  patients,  independent  of  the  fasting  plasma  glucose  levels.  The  membrane 
response to EGCG was higher in the subgroups with an increased inflammatory profile, (Figure 6). 
Thus, the increase of the anisotropy under the effect of EGCG was correlated (Sperman test) with the 
MCP-1 level, for the HGHC group (p = 0.038). 
Figure 6. Q and EGCG effect on the PBMCs membrane anisotropy values in subgroups  
(a)  absolute  anisotropy  value  for  each  subgroup;  (b)  %  membrane  anisotropy  increase 
(calculated  according  to  Equation  2)  under  the  effect  of  Q  and  EGCG  (*  p  <  0.01, 
compared to NGNC subgroup).  
 
(a) 
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Figure 6. Cont. 
 
(b) 
Statistical  analysis  of  the  results  examining  transmembrane  potential,  reveal  that  the  absolute 
fluorescence intensity of DiBAC4(3) labeled PBMCs isolated from hyperglycemia patients (diabetes group) 
regardless  of  their  TC  level  is  significantly  reduced  compared  to  the  corresponding  value  from 
normoglycemia subjects (151.72 ±  27.11, compared to 170.03 ±  39.97, p = 0.05). Treatment of the 
cells  with  the  two  polyphenolic  compounds  leads  to  a  reduction  of  fluorescence  intensity  of  the 
DiBAC4(3)  labeled  PBMCs,  corresponding  to  a  hyperpolarization  effect  [24].  The  EGCG 
hyperpolarizing effect was stronger for both groups (5.80% for normoglycemia subjects and 9.58% for 
diabetes compared to Q that induced a 4.42% effect on normoglycemia subjects and a 5.99% effect on 
HG  patients).  These  results  suggested  a  higher  susceptibility  of  hyperglycemia  to  impair  the  
voltage-gated activity of the ion  channels, as membrane potential is mainly governed by the ions 
movement across the membrane and the hyperpolarization effect of the polyphenols was increased for 
HG cells. The NGNC cells had the highest fluorescence emission intensity value (10–20% higher than 
each of the other subgroups), while all the other three subgroups had similar values for this parameter 
(Figure 7). 
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Figure 7. Hyperpolarizing effect (decrease in the DiBAC4(3) fluorescence intensity value) 
induced by treatment of PBMCs with 10 µM Q or EGCG. (a) for HG cells compared to 
NG ones; (b) for the subgroups defined depending on fasting plasma glucose and total 
cholesterol  levels.  (*  denotes  significantly  reduced  absolute  fluorescence  intensity  of 
DiBAC4(3) labeled PBMCs isolated from HG group compared to the corresponding value 
from NG subjects). 
 
(a) 
 
(b) 
2.2.4. Discussion 
Membrane  anisotropy  and  transmembrane  potential  are  among  the  most  important  biophysical 
properties of cell membranes. There are several research reports that link the microviscosity of cell 
membranes to the effects induced by different toxic stimuli. The increase of hepatocytes membrane 
fluidity under the influence of some xenobiotics (such as tacrine, ximelagatran or ethanol) is related to 
drug induced liver injury and leads to substantial disturbances of cell function [25,26]. Incubation with 
oxidized  LDL  particles  induced  an  increase  of  the  endothelial  cells  membrane  fluidity  and  
α-tocopherol prevented this effect [27,28]. Int. J. Mol. Sci. 2012, 13  4850 
 
 
According to literature data, flavonoids are modified in the small intestine and liver, mostly by 
deglycosylation.  For  example  quercetin  is  metabolised  and  three  major  metabolites  quercetin  
3'-sulfate, quercetin 3-glucuronide and 3'-methylquercetin 3-glucuronide (isorhamnetin 3-glucuronide) 
are  generated.  Previous  studies  pointed  out  the  fact  that,  at  10  µM  level  of  exposure,  the  main 
metabolites of Q did not have a significant effect on the expression of inflammatory molecules, in 
endothelial as well as in smooth muscle cells [13,14]. In the case of the present study the metabolism 
of the tested compounds is not particularly relevant since the in vitro short-time exposure (20 min) to 
the polyphenols is tested, and we suppose that the differences in membrane properties are due to 
previous in vivo disturbances in the structure and/or functions of PBMCs from diabetes patients. Still, 
in correlation with literature data, we can assume the effects of the main metabolites of the tested 
compounds on membrane anisotropy to be minimum, since our results were analyzed in correlation 
with the inflammatory profile of the patients.  
Literature  data  suggest  several  pathways  for  the  role  of  dietary  polyphenols:  interaction  with 
macromolecules [29], hormesis and synergy [30,31], interaction with estrogen receptors (ER) [32,33]; 
all  of  which  have  been  demonstrated  to  induce  cytotoxicity  in  cancer  cell  lines  (breast  cancer, 
osteosarcoma, human cervix epitheloid carcinoma, etc.). In a recent study by Galluzzo et al., doses from  
1 µ M, and up to 100 µ M, were shown to decrease the number of cells in the human cervix epitheloid 
carcinoma cell line (HeLa) that were ER-α -positive but not the number of HeLa cells that were ER-α  
-delete  [32]. Sotoca  et  al. recently proved that Q  has  increased affinity  for ER-β  at  50  µM [34]. 
According  to  Phiel  et  al.  [35],  peripheral  blood  CD8
+  T  cells  and  monocytes  express  low  but 
comparable  levels  of  both  ERs.  Also,  Pierdominici  et  al.  confirmed  that  CD4
+  and  CD8
+  T 
lymphocytes, B lymphocytes and NK cells contain intracellular ER-α and ER-β [36]. 
In the case of our study, 47.06% were females (48% in the NG group and 48.15% in the HG group). 
Therefore we consider that the affinity of Q for estrogen receptors is not relevant, since the distribution 
of the patients depending on sex is quite similar between the two groups; so we considered that the 
effects on PBMC membrane fluidity and transmembrane potential are not greatly influenced by this factor. 
We  selected  the  membrane  anisotropy  of  PBMCs  as  a  marker  of  leukocyte  function  because 
literature states that the plasma membrane fluidity of these cells influences insulin resistance, insulin 
activity and also their phagocytic properties [16,37]. The literature regarding leukocyte membrane 
fluidity  in  diabetes  is  conflicting,  probably  due  to  the  different  methodology  for  cell  isolation.  
Masuda et al. [38] reported a reduction of membrane fluidity for polymorphonuclear cells isolated 
from streptozotocin induced diabetic rats, Kantar et al. [39] showed that, in a group of type 1 diabetes 
patients the PMN membrane fluidity decreased compared to controls and Tong et al. [37] observed an 
increase in mononuclear membrane fluidity in a group of type 2 diabetics. Our results, in agreement 
with  those  obtained  by  Tong  et  al.,  showing  the  decrease  of  the  membrane  fluidity  (increase  of 
anisotropy) under the effect of the tested polyphenols, could illustrate a beneficial outcome of the 
flavonoid  exposure;  this  conclusion  is  in  agreement  with  several  studies  that  link  the  increase  of 
membrane fluidity for different types of cells with adverse/toxic effects of xenobiotics [25,26,37]. 
The evaluation of baseline membrane anisotropy for all the selected patients showed that diabetes 
patients had lower r values compared to the normoglycemia group, therefore the membranes of cells 
isolated from hyperglycemia patients, exposed to a mild inflammatory condition, are more fluid. Also, 
the  decrease  of  the  anisotropy  value  in  diabetes  patients,  could  be  a  result  of  the  fact  that Int. J. Mol. Sci. 2012, 13  4851 
 
 
hyperglycemia is associated with oxidative stress. The reactive oxygen species generated in excess in 
such conditions could influence in a negative manner the membrane function, thus having an impact 
on the membrane fluidity.  
The adhesion of circulating leukocytes to endothelial cells plays an important role in the initiation 
of atherosclerosis. There are studies suggesting that elevated plasma levels of some cellular adhesion 
molecules (ICAM-1, VCAM-1, E-selectin) might be an index of endothelial activation and a molecular 
marker of early atherosclerosis [40]. Hyperglycemia, alone and associated with hypercholesterolemia 
induces an inflammatory response and an increased adherence of leucocytes to the endothelium. 
Monocyte chemotactic protein-1 (MCP-1) is a chemokine expressed by adipocytes, smooth muscle 
and  endothelial  cells  when  exposed  to  inflammatory  stimuli,  which  plays  a  crucial  role  in  the 
recruitment  of  monocytes  and  T  lymphocytes  into  tissues.  MCP-1  level  is  stimulated  by  chronic 
hyperglycemia [41]. For the selected patients, the ICAM-1 level was higher for T2D patients, but the 
difference was not statistically significant; MCP-1 was the inflammatory marker that best discriminated 
T2D patients from normoglycemic ones. The association of hypecholesterolemia led to a significant 
increase of MCP-1 level for both normoglycemia and hyperglycemia patients. The MCP-1 level is 
significantly  increased  in  hypercholesterolemia  subgroups,  compared  to  normocholesterolemia 
subgroups, for patients with normal (p = 0.003) and pathological levels (p = 0.03) of fasting plasma 
glucose. The patients characterized by both hyperglycemia and hypercholesterolemia were the most 
affected by inflammatory and cell adhesive impairments. 
C-reactive protein is an extremely sensitive marker of chronic low-grade inflammation. Elevated 
high-sensitivity C-reactive protein (hsCRP) might potentially be a cause underlying the etiology and 
manifestation of type 2 diabetes, as well as being a powerful predictor of cardiovascular disease [42]. 
CRP distribution depending on both Gli and TC shows a large variation, but reveals the fact that the 
subgroup with high levels of both Gli and TC is characterized by a 84.51% increase of the hsCRP 
compared to the subgroup with normal values of both Gli and TC. 
Human  studies  proved  that  resistin  is  expressed  primarily  in  inflammatory  cells  and  that  may 
contribute to the metabolic and hemodynamic complications of obesity and hyperglycemia [43,44].  
In our study, resistin levels increased significantly in HG patients, either NC or HC, the increase being 
correlated with that of HOMA-IR. 
Our results show that the baseline membrane anisotropy had the highest value for cells isolated 
from normoglycemia-normocholesterolemia patients, compared to all other three subgroups. Patients 
affected by hyperglycemia, associated or not to hypercholesterolemia displayed a significant reduction 
of the anisotropy value. Not previously reported by literature, our results show that the r values are 
correlated with the resistin level and the HOMA-IR parameter for the patients; the significant increase 
of the resistin and HOMA-IR is associated with a decrease of the membrane anisotropy and therefore 
with an increase of the membrane fluidity. 
Q and EGCG induced dose-dependent membrane stiffening in PBMCs isolated from healthy donors. 
The  in  vitro  short  term  effect  of  10  µM  Q  and  EGCG  resulted  in  an  increase  of  the  membrane 
anisotropy. The EGCG effect was higher on cells isolated both from normoglycemia patients and T2D 
patients.  Our results  could  explain the beneficial effects  of Q and EGCG supported by published 
literature,  since  previous  studies  have  shown  that  the  elevation  of  membrane  anisotropy  led  to 
substantial disturbances of cell function and could be linked to toxic effects of different xenobiotics [26]. Int. J. Mol. Sci. 2012, 13  4852 
 
 
Analysis of the effects, depending both on fasting plasma glucose and cholesterol levels, shows that 
the effect of the two tested compounds was lower on the most rigid membranes from the NGNC 
subgroup. EGCG induced higher effects on the membranes isolated from patients characterized by 
hypercholesterolemia  as  well  as  by  higher  levels  of  MCP-1.  Both  polyphenols  tend  to  increase 
membrane rigidity; Q and EGCG tend to normalize the PBMCs membrane anisotropy of the cells 
isolated from hyperglycemia patients, making it similar to that of PBMC isolated from controls. 
The two polyphenols induced a hyperpolarizing effect on the PBMCs isolated from healthy donors, 
this effect also being dose dependent. Taking into account results of Verstraeten et al. [6] we can 
speculate that the effect on the transmembrane potential is due to the modulation of calcium fluxes. 
Q and EGCG induced hyperpolarization in all patients. The effects were stronger in the case of cells 
isolated from hypercholesterolemia patients, with or without associated hyperglycemia, suggesting a 
higher defenselessness of the PBMCs to polyphenols in respect of the voltage-gated activity of the  
ion channels. 
The reduction of the membrane anisotropy and transmembrane potential of PBMCs isolated from 
patients with hyperglycemia and/or hypercholesterolemia could be correlated with the increased risk of 
cardio-vascular  disease  indicated  by  literature  data  for  these  categories  of  patients.  For  subjects 
characterized  by  insulin  resistance  (increased  levels  of  resistin  and  HOMA-IR),  also  reported  
as being with high risk of atherosclerosis, cell membranes were more fluid, compared to those of 
normoglycemia/normocholesterolemia; the decrease of the membrane anisotropy in these cathegories 
of  patients  could  lead  to  an  impaired  function  of  blood  cells  and  to  an  increased  risk  of  stable 
interaction with the endothelial cells, constituting the initiating phase of atherosclerosis.  
In direct correlation, the fact that the two tested polyphenols induced an increase of the membrane 
anisotropy for cells isolated from HG patients, bringing it to the level of that of cells isolated from 
normoglycemia subjects, could constitute a mechanism responsible for the reduction of cardio-vascular 
disease incidence reported for polyphenolic compounds. The effect  of the tested polyphenols  was 
higher  for  cells  isolated  from  hypercholesterolemia  patients,  so  in  the  case  of  these  patients,  the 
administration of polyphenol rich diets could have a higher impact on the cardio-vascular function, 
compared to the hyperglycemia patients [45].  
3. Experimental Section  
3.1. Materials and Devices  
HPLC grade Q from Merck and EGCG from Sigma were used for the in vitro stimulation of the 
cells. The stock solutions (10 mM Q in DMSO and EGCG in water) were kept at −20 ° C between 
different day experiments. Hystopaque 1077 from Sigma was used for the separation of PBMCs and 
RPMI 1640 (supplemented with L-glutamate) from Merck was used as the main medium for the cell 
suspensions  during  all  tests  performed.  TMA-DPH  (1-(4-trimethylammoniumphenyl)-6-phenyl-1,3, 
5-hexatriene  p-toluensulfonate)  was  purchased  from  Molecular  Probes  and  used  as  a  membrane 
anisotropy fluorescence probe. bis-(1,3-dibutylbarbituric acid) trimethine oxonol (DiBAC4(3)) from 
Molecular  Probes  was  used  as  a  fluorescent  probe  for  the  evaluation  of  transmembrane  potential 
changes under the influence of the two polyphenols. Int. J. Mol. Sci. 2012, 13  4853 
 
 
The biochemical evaluation of the subjects was performed using an Olympus 400 analyzer, with 
Biorad  and  Randox  enzymatic  commercial  kits.  The  levels  of  hsCRP  (C-reactive  protein),  
MCP-1(monocytechemoatractant protein-1), ICAM-1 (intercellular adhesion molecule 1), insulin and 
resistin were evaluated on an automatic ChemWell 1000 system using ELISA kits (Invitrogen Inc.). 
The  insulin  resistance  index  (HOMA-IR)  induced  by  homeostatic  model  analysis,  was  calculated 
depending on the fasting plasma insulin and fasting plasma glucose [46,47]. 
The cell membrane anisotropy and transmembrane cell potential evaluations were performed using 
a LS 50B Perkin Elmer spectrofluorimeter equipped with thermostated cell holder, magnetic stirring 
and fluorescence polarization accessory. 
3.2. Study Design  
We recruited 26 type 2 diabetes patients (HG group), 34 to 77 years old, diagnosed according to the 
American  Diabetes  Association  criteria.  Results  were  matched  against  a  group  made  up  of  25 
normoglycemia subjects (NG group), 35 to 76 years old, who presented at the hospital for routine 
check-ups. Patients with severe renal, hepatic or hematological disease, overt cardiovascular disease or 
malignancy were excluded. All the patients in the study had a diabetes history of 2–4 years and were 
treated with metformin (46.15% of the HG group) or gliclazide (53.85%). None of the subjects had 
taken known antioxidants-containing supplements (vitamin C, vitamin E, probucol, etc.) two weeks 
prior to the study. All subjects in the normoglycemia group had a negative family history of diabetes. 
The study was approved by the local Ethics Committee and informed consent was obtained from the 
patients and healthy subjects. 
For the selected patients,  type 2 diabetes was  diagnosed not  only based on the fasting plasma 
glucose levels,  but  also  on glycated hemoglobin.  In the diabetes  group we included patients  with 
HbA1c levels higher than 6.6%.  
We wanted to analyze data depending not only on fasting plasma glucose level, but also on the 
cholesterol level, so all selected patients were divided into four subgroups: 
  NGNC subgroup, n = 15, included normoglycemia (fasting plasma glucose, Gli < 110 mg/dL) 
normocholesterolemia (total cholesterol, TC < 200 mg/dL) subjects. 
  NGHC subgroup, n = 10, included normoglycemia-hypecholesterolemia (TC > 200 mg/dL) patients. 
  HGNC subgroup, n = 12, included hyperglycemia (Gli > 110 mg/dL) normocholesterolemia patients. 
  HGHC subgroup, n = 14, included hyperglycemia-hypercholesterolemia patients. 
3.3. Biological Samples  
Fasting venous blood samples drawn on Na2EDTA as anticoagulant were used for the isolation of 
PBMCs. The PBMCs were separated using the gradient density method, with Hystopaque 1077 [48]. 
Separated PBMCs (monocytes and lymphocytes) were washed three times with RPMI 1640 medium, 
standardized at 10
5 cells/mL and used for the spectrofluorimetric assay [49,50]. Platelet rich plasma 
samples were used for the biochemical evaluation. 
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3.4. Methods  
3.4.1. Fluorescence Anisotropy Measurements 
The  cell  membrane  anisotropy  measurements  were  performed  by  evaluation  of  TMA-DPH 
anisotropy  values  in  a  steady  state  fluorescence  polarization  experiment,  after  the  cell  membrane 
exterior phospholipids layer permeation of the probe [51–53]. 
The  fluorescence  anisotropy  of  TMA-DPH  labeled  PBMCs  was  evaluated  prior  and  after  
20 min of incubation, at room temperature, with Q or EGCG. For this purpose, the normalized cell 
suspension labeled with 2.5 µM TMA-DPH (2 min incubation, at 37 ° C, under continuous magnetic 
stirring) was excited with polarized light at 340 nm and the emission intensities were detected at  
425 nm. The measurements were carried out for the four possible positions of the polarizers in the 
excitation and emission beam; each relative emission intensity value was computed as a mean of  
200 points (measurements in a total time of 4 s in steps of 0.02 s). The calculation of the fluorescence 
anisotropy (r) was performed according to Equation (1):  
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where  Ivv,  Ivh,  Ihv  and  Ihh  represent  the  emission  intensity  when  the  polarizers  in  the  excitation  
and  emission  beams  are  oriented  vertical-vertical,  vertical-horizontal,  horizontal-vertical  and  
horizontal-horizontal, respectively, and G = Ihv/Ihh is an instrumental factor [54]. 
The effect was evaluated as relative anisotropy change following Equation (2): 
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where  rf  is  the  anisotropy  after  the  cells  exposure  to  polyphenols  and  ri  the  basal  anisotropy  of  
the cells. 
3.4.2. Transmembrane Potential Evaluation 
DiBAC4(3) is a slow-response potential-sensitive probe that can enter depolarized cells, binds to the 
membrane and thus exhibits enhanced fluorescence. Depolarization results in an additional influx of 
the  anionic  dye  and  consequently  an  increase  in  the  fluorescence.  Conversely,  hyperpolarization 
(increase in the absolute value of the membrane potential) is indicated by a decrease in fluorescence [24]. 
DiBAC4(3) labeled PBMCs in a normalized suspension (2 µ M probe concentration for 10
5 cells/mL) 
were excited at 493 nm and fluorescence emission spectra were collected within the range 500 to  
600 nm, with a maximum at 517 nm. Fluorescence intensity was measured before and after 20 min 
incubation of the cells with Q or EGCG. The membrane potential changes were evaluated as a relative 
effect of the two polyphenols using Equation (3): 
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where  I0  is  the  fluorescence  intensity  of  untreated  cells  and  If  is  the  fluorescence  intensity  after 
incubation with Q or EGCG. 
The two fluorescent probes were added simultaneously, and the fluorescent signals were collected 
successively, after performing tests that showed that the two probes do not interfere (discussed above) 
and the final results were not statistically affected by the successive measurements of the signals. 
3.4.3. Statistical Analysis 
Results are expressed as means ±  standard deviation. For comparison among the groups we used 
one-way ANOVA and Bonferroni t-test, as well as Student’s paired t test. Multiple regression analysis 
was performed to evaluate the interrelations between studied parameters using the Statistical Package 
for Social Sciences software (SPSS) version 15. For correlations between the parameters, bivariate 
correlation procedures (Spearman’s correlation coefficent) were used.  Differences  were considered 
significant for p < 0.05. 
4. Conclusions  
The  influence  of  two  natural  diet  polyphenols  (Q  and  EGCG)  on  membrane  anisotropy  and 
transmembrane  potential  of  PBMCs  from  normal  and  hyperglycemic  patients  was  studied,  in  a  
double-staining procedure. Q and EGCG displayed a dose dependent hyperpolarizing and stiffening 
effect on PBMCs, exerted in vitro, at physiologic as well as at supraphysiologic levels of exposure. 
The PBMCs anisotropy was lower for type 2 diabetes patients compared to normoglycemia ones. 
Hypercholesterolemia, as well as hyperglycemia strongly impacts the membrane fluidity. Our results 
show that the increase of the resistin levels and HOMA-IR was associated with a significant increase 
of the membrane fluidity. 
Physiological levels of Q and EGCG tend to normalize the PBMCs membrane anisotropy values of 
the cells isolated from T2D patients, making it similar to that of PBMCs isolated from normoglycemia 
ones.  The  effect  of  the  two  tested  compounds  was  low  on  the  more  rigid  membranes  from 
normoglycemia-normocholesterolemia patients. Both polyphenols tend to increase membrane rigidity, 
EGCG being more effective than Q.  The stiffening effect  exhibited by EGCG is  greater on cells 
isolated from hypercholesterolemia patients. 
Q  and  EGCG  have  a  strong  hyperpolarizing  effect  on  cells  isolated  from  patients  with 
hypercholesterolemia, regardless of associated hyperglycemia. The hyperpolarizing effect is not linked 
to the inflammatory profile of the patients. The decrease of the membrane fluidity and the hyperpolarizing 
effect could explain the cardiovascular protective action of the tested compounds. Flavonoids could 
improve PBMCs membrane function not only by providing an antioxidant protection through free 
radical scavenging but also by modulating the membrane fluidity and transmembrane potential. 
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